RX Drugnews homepage



  • Privacy Policy

       



    1. AGREEMENT
    By using this website, you are agree, without limitation or qualification, to be bound by, and to comply with, these Terms and Conditions and any other posted guidelines or rules applicable to any individual RxDrug News Network web site.

    RxDrugNews.com respects your privacy. We will never rent or sell your email address to any third parties. We will never send you third-party solicitations. We will protect your email address and promptly honor all unsubscribe requests.

    RxDrugNews.com is 100% compliant with the federal CAN-SPAM Act.

    Furthermore, RxDrugNews.com will never share its subscriber database with any government agency such as the FDA. In fact, DrugNews Publishing (the company that owns RxDrugNews.com) operates outside the United States and does not answer to U.S. authorities.

    2. RIGHT TO ACCESS
    You acknowledge and agree that RxDrug News may terminate your access to the RxDrug News Network or to any of the Products and Services should you fail to comply with the Terms and Conditions or any other guidelines and rules published by RxDrug News.com. Any such termination shall be in RxDrug News's sole discretion and may occur without prior notice, or any notice. RxDrug News further reserves the right to terminate any user's access to the RxDrug News Network or to any of the Products and Services for any conduct that RxDrug News, in its sole discretion, believes is or may be directly or indirectly harmful to other users, to RxDrug News or its subsidiaries, affiliates, or business contractors, or to other third parties, or for any conduct that violates any local, state, federal, or foreign laws or regulations. RxDrug News further reserves the right to terminate any user's access to the RxDrug News Network for any reason or for no reason at all, in RxDrug News's sole discretion, without prior notice, or any notice.

    3. COPYRIGHT
    All information contained on this site is copyright (c) 2003, 2004, 2005, 2006, 2007, 2008 by DrugNews Publishing, Inc. ("RxDrug News"). All rights reserved. The information contained on this site may not be copied, published, distributed, broadcast or otherwise used for any purpose whatsoever without the prior written consent of RxDrug News.

    4. PROFESSIONAL ADVICE
    No information on this site is intended as, or shall be construed as, legal, financial, medical or expert advice of any kind. RxDrug News is not responsible for typographical errors, editing errors, or news source errors. THE RxDrug News NETWORK STRONGLY SUGGESTS THAT YOU SEEK ADVICE FROM A COMPETENT PROFESSIONAL REGARDING ISSUES IN ANY PROFESSIONAL FIELD.

    5. DISCLAIMER OF WARRANTIES
    THE INFORMATION ON THIS WEBSITE IS PROVIDED "AS IS," WITH NO WARRANTIES WHATSOEVER. ALL EXPRESS, IMPLIED, AND STATUTORY WARRANTIES, INCLUDING, WITHOUT LIMITATION, THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT OF PROPRIETARY RIGHTS, ARE EXPRESSLY DISCLAIMED TO THE FULLEST EXTENT PERMITTED BY LAW. TO THE FULLEST EXTENT PERMITTED BY LAW, RxDrug News DISCLAIMS ANY WARRANTIES FOR THE SECURITY, RELIABILITY, TIMELINESS, AND PERFORMANCE OF THE INFORMATION ON THIS WEBSITE. TO THE FULLEST EXTENT PERMITTED BY LAW, RxDrug News DISCLAIMS ANY WARRANTIES FOR OTHER SERVICES OR GOODS RECEIVED THROUGH OR ADVERTISED ON THE WEBSITE OR RECEIVED THROUGH ANY LINKS PROVIDED IN THE WEBSITE, AS WELL AS FOR ANY INFORMATION OR ADVICE RECEIVED THROUGH THE WEBSITE OR THROUGH ANY LINKS PROVIDED IN THE WEBSITE. RxDrug News SIMILARLY DISCLAIMS, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY WARRANTIES FOR ANY INFORMATION OR ADVICE OBTAINED THROUGH THE WEBSITE.

    YOU EXPRESSLY UNDERSTAND AND AGREE THAT RxDrug News DISCLAIMS ANY AND ALL RESPONSIBILITY OR LIABILITY FOR THE ACCURACY, CONTENT, COMPLETENESS, LEGALITY, RELIABILITY, OR OPERABILITY OR AVAILABILITY OF INFORMATION OR MATERIAL IN THE WEBSITE. RxDrug News DISCLAIMS ANY RESPONSIBILITY FOR THE DELETION, FAILURE TO STORE, MISDELIVERY, OR UNTIMELY DELIVERY OF ANY INFORMATION OR MATERIAL. RxDrug News DISCLAIMS ANY RESPONSIBILITY OR LIABILITY FOR ANY HARM RESULTING FROM DOWNLOADING OR ACCESSING ANY INFORMATION OR MATERIAL THROUGH THE WEBSITE, INCLUDING, WITHOUT LIMITATION, FOR HARM CAUSED BY VIRUSES OR SIMILAR CONTAMINATION OR DESTRUCTIVE FEATURES. RxDrug News MAKES NO WARRANTY REGARDING THE RELIABILITY OR ACCESSIBILITY OF WEB PAGES OR ANY STORAGE FACILITIES OFFERED BY RxDrug News.

    YOU UNDERSTAND AND AGREE THAT ANY MATERIAL DOWNLOADED OR OTHERWISE OBTAINED THROUGH THE USE OF THE WEBSITE IS DONE AT YOUR OWN DISCRETION AND RISK AND THAT YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGES TO YOUR COMPUTER SYSTEM OR LOSS OF DATA THAT RESULTS IN THE DOWNLOAD OF SUCH MATERIAL.

    Some jurisdictions do not allow the disclaimer of implied warranties. In such jurisdictions, the foregoing disclaimers may not apply to you insofar as they relate to implied warranties.

    6. LIMITATION OF LIABILITY
    YOU EXPRESSLY UNDERSTAND AND AGREE THAT UNDER NO CIRCUMSTANCES SHALL DrugNews PUBLISHING, INC. ("RxDrug News") ITS EMPLOYEES, OFFICERS, WRITERS, CONTRACTORS, OR PRINCIPALS BE LIABLE TO ANY USER'S USE OR MISUSE OF AND RELIANCE ON THE WEBSITE. SUCH LIMITATION OF LIABILITY SHALL APPLY TO PREVENT RECOVERY OF DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY, AND PUNITIVE DAMAGES (EVEN IF RxDrug News OR ITS LICENSORS HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES). SUCH LIMITATION OF LIABILITY SHALL APPLY WHETHER THE DAMAGES ARISE FROM USE OR MISUSE OF AND RELIANCE ON THE WEBSITE, FROM INABILITY TO USE THE WEBSITE, OR FROM THE INTERRUPTION, SUSPENSION, OR TERMINATION OF THE WEBSITE (INCLUDING SUCH DAMAGES INCURRED BY THIRD PARTIES).

    SUCH LIMITATION SHALL ALSO APPLY WITH RESPECT TO DAMAGES INCURRED BY REASON OF OTHER SERVICES OR GOODS RECEIVED THROUGH OR ADVERTISED ON THE WEBSITE OR RECEIVED THROUGH ANY LINKS PROVIDED IN THE WEBSITE, AS WELL AS BY REASON OF ANY INFORMATION OR ADVICE RECEIVED THROUGH OR ADVERTISED ON THE WEBSITE OR RECEIVED THROUGH ANY LINKS PROVIDED IN THE WEBSITE. SUCH LIMITATION SHALL APPLY, WITHOUT LIMITATION, TO THE COSTS OF PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES, LOST PROFITS, OR LOST DATA. SUCH LIMITATION SHALL APPLY WITH RESPECT TO THE PERFORMANCE OR NON-PERFORMANCE OF THE WEBSITE OR ANY INFORMATION OR MERCHANDISE THAT APPEARS ON, OR IS LINKED OR RELATED IN ANY WAY TO, THE RxDrug News NETWORK. SUCH LIMITATION SHALL APPLY NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. SUCH LIMITATION SHALL APPLY TO THE FULLEST EXTENT PERMITTED BY LAW.

    SUCH LIMITATION OF LIABILITY SHALL ALSO APPLY TO ANY DAMAGE CAUSED BY LOSS OF ACCESS TO, DELETION OF, FAILURE TO STORE, FAILURE TO BACK UP, OR ALTERATION OF WEB PAGES OR OTHER CONTENT STORED THROUGHT THE RxDrug News NETWORK.

    UNDER NO CIRCUMSTANCES SHALL RxDrug News OR ITS LICENSORS BE HELD LIABLE FOR ANY DELAY OR FAILURE IN PERFORMANCE RESULTING DIRECTLY OR INDIRECTLY FROM ACTS OF NATURE, FORCES, OR CAUSES BEYOND ITS REASONABLE CONTROL, INCLUDING, WITHOUT LIMITATION, INTERNET FAILURES, COMPUTER EQUIPMENT FAILURES, TELECOMMUNICATION EQUIPMENT FAILURES, OTHER EQUIPMENT FAILURES, ELECTRICAL POWER FAILURES, STRIKES, LABOR DISPUTES, RIOTS, INSURRECTIONS, CIVIL DISTURBANCES, SHORTAGES OF LABOR OR MATERIALS, FIRES, FLOODS, STORMS, EXPLOSIONS, ACTS OF GOD, WAR, GOVERNMENTAL ACTIONS, ORDERS OF DOMESTIC OR FOREIGN COURTS OR TRIBUNALS, NON-PERFORMANCE OF THIRD PARTIES, OR LOSS OF OR FLUCTUATIONS IN HEAT, LIGHT, OR AIR CONDITIONING.

    In some jurisdictions, limitations of liability are not permitted. In such jurisdictions, the foregoing limitation may not apply to you.

    7. EXTERNAL LINKS
    RxDrug News may provide, or third parties may provide, links to other sites or resources located on the World Wide Web by allowing a user to leave the RxDrug News Network to access third-party material or by bringing the third party material into this site via "inverse" hyperlinks and framing technology. RxDrug News has no control over such sites and resources. You acknowledge and agree that RxDrug News is not responsible for the availability of such external sites or resources, and does not endorse and is not responsible or liable for any content, advertising, products, or other materials on or available from such sites or resources. You further acknowledge and agree that RxDrug News shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with use of or reliance on any such content, goods or services available on or through any such site or resource.

    Your correspondence or business dealings with, or participation in promotions of, advertisers found on or through the RxDrug News Network Products and Services, including payment and delivery of related goods or services, and any other terms, conditions, warranties or representations associated with such dealings, are solely between you and such advertiser. You agree that RxDrug News shall not be responsible or liable for any loss or damage of any sort incurred as the result of any such dealings or as the result of the presence of such advertisers on the Product and Services.

    RxDrug News encourages you to exercise discretion while using the Products and Services to browse the Internet. RxDrug News may produce automated search results or otherwise link you to sites containing information that some people may find inappropriate or offensive. RxDrug News makes no representations concerning any effort to review the content of any of the sites listed in automated search results, or of any of the sites otherwise linked to the RxDrug News Network web sites. RxDrug News shall not be held responsible for the accuracy, copyright or trademark compliance, legality, or decency of material contained in sites listed in the RxDrug News Network' search results or otherwise linked to the RxDrug News Network web sites or provided to the RxDrug News Network by third parties.

    8. Linking to the RxDrug News Network
    The RxDrug News Network offers a non-assignable, non-transferable, and non-exclusive license to link to the RxDrug News Network'S web sites, using the RxDrug News Network logos and search boxes, subject to the following provisions. The RxDrug News Network logos and search boxes may be placed on a Web site for the sole purpose of creating a link to the RxDrug News Network and allowing users of your site to access the RxDrug News Network. The RxDrug News Network logos and search boxes may not be used for any other purpose, including, among other purposes, to suggest sponsorship by, or affiliation with, or endorsement by the RxDrug News Network.

    The RxDrug News Network logos and search boxes may not be altered in any manner. The RxDrug News Network logos and search boxes must appear by themselves, with reasonable spacing (at least the height of the logo) between each side of the applicable logo or search box and other graphic or textual elements. The RxDrug News Network logos and search boxes may not be used to disparage the RxDrug News Network, its products or services, or in a manner which, in RxDrug News's reasonable judgment, may diminish or otherwise damage RxDrug News's good will in the RxDrug News Network logos. By using any such RxDrug News Network logo or search box, you acknowledge that the RxDrug News Network has exclusive rights to the logo or search box, and that all good will generated through your use of the logo or search box will inure to the benefit of the RxDrug News Network. RxDrug News reserves the right to revoke this license or to alter its terms from time to time, for any or no reason, with or without notice. RxDrug News reserves the right to take action against any use that does not conform to these provisions.

    9. NO LICENSE; INTELLECTUAL PROPERTY OF RxDrug News AND OTHERS
    Except as expressly provided, nothing within any of the WEBSITE shall be construed as conferring any license under any of the RxDrug News Network's or any third party's intellectual property rights, whether by estoppel, implication, waiver, or otherwise. Without limiting the generality of the foregoing, you acknowledge and agree that certain Content available through and used to operate the RxDrug News Network and the WEBSITE is protected by copyright, trademark, patent, or other proprietary rights of RxDrug News and its affiliates, licensors, and service providers. Except as expressly provided to the contrary, you agree not to modify, alter, or deface any of the trademarks, service marks, or other intellectual property made available by RxDrug News in connection with the WEBSITE. You agree not to hold yourself out as in any way sponsored by, affiliated with, or endorsed by RxDrug News, any of RxDrug News's affiliates, or any of RxDrug News's service providers. You agree not to use any of the trademarks or service marks or other Content accessible through the RxDrug News Network of any purpose other than the purpose for which such Content is made available to users by RxDrug News. You agree not to defame or disparage RxDrug News, the trademarks or service marks of RxDrug News, or any aspect of the WEBSITE. You agree not to adapt, translate, modify, decompile, disassemble, or reverse engineer the WEBSITE or any software or programs used in connection with the WEBSITE or the RxDrug News Network.

    10. INDEMNITY AND RELEASE
    By using the RxDrug News Network web sites you agree to indemnify RxDrug News, Inc. and its parents, subsidiaries, affiliates, officers, employees, and licensors and hold them harmless from any and all claims and expenses, including attorney's fees, arising from your use of the RxDrug News Network web sites, your use of the WEBSITE, or your submission of ideas and/or related materials to RxDrug News or from any person's use of any account or password you maintain with any portion of the RxDrug News Network, regardless of whether such use is authorized by you. By using the RxDrug News Network, using the WEBSITE, or submitting any ideas and/or related materials to RxDrug News, you are hereby agreeing to release RxDrug News and its parents, subsidiaries, affiliates, officers, employees, and licensors from any and all claims, demands, debts, obligations, damages (actual or consequential), costs, and expenses of any kind or nature whatsoever, whether known or unknown, suspected or unsuspected, disclosed or undisclosed, that you may have against them arising out of or in any way related to such disputes and/or to the WEBSITE or to any disputes regarding use of ideas and/or related materials submitted to RxDrug News. YOU HEREBY AGREE TO WAIVE ALL LAWS THAT MAY LIMIT HE EFFICACY OF SUCH RELEASES. FOR EXAMPLE, YOU SPECIFICALLY AGREE TO WAIVE THE PROVISIONS OF CALIFORNIA CIVIL CODE SECTION 1542, WHICH PROVIDES

    " A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IS KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR."

    11. LIMITATION OF ACTIONS
    You acknowledge and agree that, regardless of any statute or law to the contrary, any claim or cause of action you may have arising out of, or relating to, your use of the RxDrug News Network or the WEBSITE must be filed within one (1) year after such claim or cause of action arises, or forever be barred.

    12. FAIR USE
    The RxDrug News Network publishes excerpts and summaries from copyrighted works under Fair Use, which allows the use of copyrighted materials for purposes of commentary and criticism for the public interest. RxDrug News transforms summaries of the original copyrighted work into a new format and adds new information and value in the form of commentary or criticism.

    RxDrug News has no intention to compete with the original copyrighted content. Rather, it is RxDrug News's intention to promote such content and deliver readers to such content. Accordingly, when RxDrug News cites a copyrighted work for commentary or criticism, RxDrug News acknowledges the original source and places a clickable link that offers users the opportunity to click directly to the original source of such information. The original publishers benefit from such links in terms of delivered audience, attention and potential advertising revenues, for which RxDrug News requests absolutely no payment or consideration.

    13. INTELLECTUAL PROPERTY INFRINGEMENT CLAIMS
    It is the policy of the RxDrug News Network to respond expeditiously to claims of intellectual property infringement. RxDrug News will promptly process and investigate notices of alleged infringement and will take appropriate actions under the Digital Millennium Copyright Act ("DMCA") and other applicable intellectual property laws. Upon receipt of notices complying or substantially complying with the DMCA, the RxDrug News Network will act expeditiously to remove or disable access to any material claimed to be infringing or claimed to be the subject of infringing activity and will act expeditiously to remove or disable access to any reference or link to material or activity that is claimed to be infringing. The RxDrug News Network will terminate access for subscribers and account holders who are repeat infringers. Notices of claimed infringement should be directed to:

    DrugNews Publishing, Inc.
    12E-2, No.141, Davidas E. MD., Lomunal District,
    Riga 105, Latvia
    Email address: copyright[ @ ] RxDrug News.com

    Please put "Notice of Infringement" in the subject line of all such notifications. When RxDrug News removes or disables access to any material claimed to be infringing, RxDrug News may attempt to contact the user who has posted such material in order to give that user an opportunity to respond to the notification, although RxDrug News makes no promise to do so. Any and all counter notifications submitted by the user will be furnished to the complaining party. RxDrug News will give the complaining party an opportunity to seek judicial relief in accordance with the DMCA before RxDrug News replaces or restores access to any material as a result of any counter notification.

    14. ARBITRATION, GOVERNING LAW AND FORUM FOR DISPUTES
    Unless expressly stated to the contrary elsewhere within the WEBSITE, all legal issues arising from or related to the use of the WEBSITE shall be construed in accordance with, and all questions with respect thereto shall be determined by, the laws of Latvian, R.O.C. applicable to contracts entered into and wholly to be performed within said state. Any controversy or claim arising out of or relating to these Terms and Conditions or any user's use of the WEBSITE shall be settled by binding arbitration in accordance with the commercial arbitration rules of the American Arbitration Association. Any such controversy or claim shall be arbitrated on an individual basis, and shall not be consolidated in any arbitration with any claim or controversy of any other party. The arbitration shall be conducted in Latvian, R.O.C., and judgment on the arbitration award may be entered into in any state or federal court in Latvian, R.O.C. having jurisdiction thereof. Any party seeking temporary or preliminary injunctive relief may do so in any state or federal court in Latvian, R.O.C. having jurisdiction thereof. Except as set forth above, the state and federal courts of Latvian, R.O.C. shall be the exclusive forum and venue to resolve disputes arising out of or relating to these Terms and Conditions or any user's use of the WEBSITE. By using the WEBSITE and thereby agreeing to these Terms and Conditions, users consent to personal jurisdiction and venue in the state and federal courts in Latvian, R.O.C. with respect to all such disputes.

    15. CHANGES IN TERMS AND CONDITIONS AND CHANGES IN WEBSITE
    The RxDrug News Network reserves the right to modify the WEBSITE from time to time, for any reason, and without notice, including the right to terminate the WEBSITE. The RxDrug News Network reserves the right to modify these Terms and Conditions from time to time, without notice. Please review these Terms and Conditions from time to time so you will be apprised of any changes.

    16. MERGER
    These Terms and Conditions constitute the entire agreement between the parties with respect to the subject matter contained herein and supersedes any other agreement, proposals and communications, written or oral, between RxDrug News's representations and you with respect to the subject matter hereof; except that any other terms and conditions located on any individual RxDrug News Network web site or in connection with the WEBSITE are incorporated herein by reference to the extent they do not conflict with these Terms and Conditions. To the extent that any other terms and conditions or terms of service conflict with these Terms and Conditions, those other provisions shall control with respect to the use of the particular web site and any information available on or through the web site or the respective content location at which those other provisions may be found.

    17. NON-WAIVER AND SEPARABILITY
    RxDrug News's failure to exercise any right or provision of these Terms and Conditions shall not constitute a waiver of such right or provision. If a court of competent jurisdiction holds any provision of these Terms and Conditions to be invalid, the parties nevertheless agree that the court should endeavor to give effect to the parties' intentions as reflected in the provision, and agree that the other provisions of these Terms and Conditions remain in full force and effect.

    18. NO RESALE, ASSIGNMENT, OR SUBLICENSING
    You agree not to resell, assign, sublicense, otherwise transfer, or delegate your rights or obligations under these Terms and Conditions without prior express written authorization of RxDrug News.

    19. SUCCESSORS AND ASSIGNS
    Without in any way limiting the prohibition on your resale, assignment, sublicensing, or other transfer of rights or obligations, these Terms and Conditions shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, successors, and assigns.

    20. TERMINATION; SURVIVAL
    These Terms and Conditions shall continue in effect for as long as you use the WEBSITE, unless specifically terminated earlier by RxDrug News. All provisions of these Terms and Conditions which impose obligations continuing in their nature shall survive termination of these Terms and Conditions.

    21. COMMUNICATIONS WITH USERS
    You consent to receive communications from RxDrug News concerning your use of the WEBSITE ("Communications"). The Communications may be those that RxDrug News is required to send to you by law concerning the WEBSITE ("Required Communications"). The Communications may also be those that RxDrug News sends to you for other reasons. You consent to receive Communications electronically. RxDrug News may provide these Communications to you by sending an email to the email address you provided or by posting the Communication on the RxDrug News Network. You also consent to receive Communications by telephone or by postal mail sent to the postal address you provided in connection with your account, if any. You may change the email or postal address to which RxDrug News sends Communications by visiting your account information page.

    22. SUBMISSIONS OF IDEAS
    The RxDrug News Network is always improving its WEBSITE and developing new features. If you have ideas regarding improvements or additions to the RxDrug News Network, we would like to hear them -- but any submission will be subject to these Terms and Conditions. UNDER NO CIRCUMSTANCES SHALL ANY DISCLOSURE OF ANY IDEA OR RELATED MATERIALS TO RxDrug News BE SUBJECT TO ANY OBLIGATION OF CONFIDENTIALITY OR EXPECTATION OF COMPENSATION. BY SUBMITTING THE IDEA AND/OR ANY RELATED MATERIAL TO RxDrug News, YOU ARE WAIVING ANY AND ALL RIGHTS THAT YOU MAY HAVE IN THE IDEA OR ANY RELATED MATERIALS AND ARE REPRESENTING AND WARRANTING TO RxDrug News THAT THE IDEA AND/OR RELATED MATERIALS ARE WHOLLY ORIGINAL WITH YOU, THAT NO ONE ELSE HAS ANY RIGHTS IN THE IDEA AND/OR MATERIALS AND THAT RxDrug News IS FREE TO IMPLEMENT THE IDEA AND TO USE THE MATERIALS IF IT SO DESIRES, AS PROVIDED OR AS MODIFIED BY RxDrug News, WITHOUT OBTAINING PERMISSION OR LICENSE FROM ANY THIRD PARTY.

    23. VIOLATIONS OF TERMS AND CONDITIONS
    Should you violate these Terms and Conditions or any other rights of RxDrug News and the RxDrug News Network, RxDrug News reserves the right to pursue any and all legal and equitable remedies against you, including, without limitation, terminating any and all access and or user accounts on any and all of the RxDrug News Network web sites.

    24. Google and the DoubleClick DART cookie
    We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

    • Google, as a third party vendor, uses cookies to serve ads on your site.
    • Google's use of the DART cookie enables it to serve ads to your users based on their visit to your sites and other sites on the Internet.
    • Users may opt out of the use of the DART cookie by visiting the Google ad and content network privacy policy.

    We hope your enjoyment of RxDrug News' WEBSITE will be enhanced by the application of these Terms and Conditions. It is our belief that your understanding of the guidelines we have set forth will allow the RxDrug News community to continue to be a place where each of us can prosper, grow, and enjoy ourselves within an open and non-threatening environment. Thank you for taking the time to read these Terms and Conditions and we hope you enjoy our WEBSITE.

    Amera Davidas
    DrugNews Publishing, Inc.
    12E-2, No.141, Davidas E. MD., Lomunal District,
    Riga 105, Latvia
    Email address: copyright[ @ ] RxDrug News.com



Subscribe to the "News" RSS Feed RSS

  ۞



 

About Us   |  Privacy Policy   |  Terms of Use   |  Contact Us  

© 2012 RxDrug News 1999-2016. All rights reserved